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MEETING REPORT
Targeted Next Generation Sequencing 
for malaria research in Africa: current status 
and outlook
Anita Ghansah1, Edwin Kamau2,3, Alfred Amambua‑Ngwa4, Deus S. Ishengoma5, Oumou Maiga‑Ascofare6, 
Lucas Amenga‑Etego7, Awa Deme8, William Yavo9,10, Milijaona Randrianarivelojosia11, Plasmodium Diversity 
Network Africa, Lynette Isabella Ochola‑Oyier12, Gideon Kofi Helegbe13, Jeffery Bailey14, Michael Alifrangis15 
and Abdoulaye Djimde16,17* 
Abstract 
Targeted Next Generation Sequencing (TNGS) is an efficient and economical Next Generation Sequencing (NGS) 
platform and the preferred choice when specific genomic regions are of interest. So far, only institutions located in 
middle and high‑income countries have developed and implemented the technology, however, the efficiency and 
cost savings, as opposed to more traditional sequencing methodologies (e.g. Sanger sequencing) make the approach 
potentially well suited for resource‑constrained regions as well. In April 2018, scientists from the Plasmodium Diver‑
sity Network Africa (PDNA) and collaborators met during the 7th Pan African Multilateral Initiative of Malaria (MIM) 
conference held in Dakar, Senegal to explore the feasibility of applying TNGS to genetic studies and malaria surveil‑
lance in Africa. The group of scientists reviewed the current experience with TNGS platforms in sub‑Saharan Africa 
(SSA) and identified potential roles the technology might play to accelerate malaria research, scientific discoveries and 
improved public health in SSA. Research funding, infrastructure and human resources were highlighted as challenges 
that will have to be mitigated to enable African scientists to drive the implementation of TNGS in SSA. Current roles of 
important stakeholders and strategies to strengthen existing networks to effectively harness this powerful technology 
for malaria research of public health importance were discussed.
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Background
The evolution of next generation sequencing (NGS) 
technologies and the accompanying bioinformatic tools 
necessary to interpret the large quantity of sequence 
data have expanded the frontiers of biomedical research. 
These advances have impacted malaria research where 
these technologies are increasingly being performed 
for studying parasite diversity and antimalarial resist-
ance in SSA [1–4], as discussed in the other papers in 
this series. Notably, NGS applications, such as Targeted 
Next Generation Sequencing (TNGS), which focuses 
on sequencing specific regions of the genome, tend to 
increase the sample load, the processing speed and at the 
same time, lower the costs of molecular analysis. Just as 
the traditional PCR technology was gradually introduced 
to every institution in SSA in the late 1990s, the relatively 
lower cost and speed of TNGS makes this technology the 
next natural step to be integrated into malaria research 
in SSA.
Currently, most malaria studies that have applied 
TNGS were funded by foreign agencies, spearheaded 
by collaborating non-SSA principal investigators, in 
collaboration with African scientists. The samples 
were processed for sequencing outside SSA after sam-
ple collection. Moreover, most of the TNGS data were 
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generated and analysed in the non-SSA countries. In 
order to address the gap in TNGS data generation and 
analysis in Africa, the Plasmodium Diversity Network 
Africa (PDNA) [5] and research collaborators from non-
SSA countries organized a workshop on the 18th of April 
2018, as part of the MIM conference. The workshop was 
entitled “Targeted Next Generation Sequencing for Pub-
lic Health” and hosted by the Institut de Recherche en 
Santé, de Surveillance Epidémiologique et de Formation, 
(IRESSEF), Diamniadio, Senegal. The workshop served as 
a platform for African researchers and their collaborat-
ing partners to discuss the status of TNGS applications 
in Africa, highlight opportunities and challenges and to 
discuss ways of bridging the gaps in application of TNGS. 
It was acknowledged that to successfully integrate TNGS 
technology for malaria research in SSA, several critical 
requirements are needed. These include; generating the 
key research/public health questions, funding, infrastruc-
ture and human resource development, engagement of 
policy makers in scientific deliberations, strengthening 
and harmonizing collaborations, and establishing/imple-
menting a regulatory framework for operating NGS and 
TNGS in SSA.
Highlights from the symposium
Malaria targeted next generation sequencing and public 
health needs in Africa
A growing role of public health practitioners is to develop 
interventions for combating malaria and to evaluate the 
ability of these interventions to reduce morbidity and 
mortality in these populations. Several applications of 
TNGS for addressing the impact of such interventions 
were highlighted during the workshop. Table  1 outlines 
potential applications of TNGS in addressing important 
public health concerns in Africa, focusing on malaria. 
At the workshop, additional possibilities of personalized 
genomics and pharmacogenomics, and links between 
parasite genetics/drug resistance/host immune response 
and vaccine efficacy were also discussed.
As discussed in other papers in this series, TNGS (and 
molecular tools in general) have significant potential, 
but have seen limited impact on public health in Afri-
can countries. Although African scientists have spear-
headed collecting and processing samples and in cases 
led the analysis of sequencing data [2, 4, 6–8], in order 
to fully operationalize TNGS to have its greatest impact 
for public health in Africa, projects need to be led and 
completed by African scientists in African institutions. 
By conducting this work in Africa, data can be generated 
in a timelier fashion, capacity built for research and data 
ownership issues minimized. The discrepancy between 
sample collection and driving studies is driven by a blend 
of general challenges facing researchers in SSA, such 
as funding, and more specific challenges relating to the 
implementation of TNGS in Africa.
Challenges faced by sub‑Saharan African scientists 
in the implementation of TNGS and the way 
forward
Infrastructural development and cost
Despite the significant decrease in sequencing costs 
over the last decade, the prices of most of the sequenc-
ing instruments and the cost of establishing a sequenc-
ing centre remain very high and beyond the budget of 
most African institutions. The few African institutions 
that have acquired lllumina MiSeq sequencers are at vari-
ous stages of operationalizing them, ranging from setting 
up of the sequencing centre to quality control testing; 
very few have begun to generate data. A large majority 
of African scientists obtain partially analysed sequence 
data from their collaborators and in rare cases outsource 
directly to commercial sequencing companies or through 
local agents of these companies. Numerous reasons were 
outlined during the discussion at the workshop, and it 
Table 1 Potential role of  targeted next  generation sequencing in  addressing malaria research of  public health 
importance in Africa
Scientific objective Application
Determination of the frequency and geographic distribution of genetic 
markers of antimalarial drug resistance
Early detection of drug resistance emergence and surveillance of the geo‑
spatial changes of antimalarial drug resistance
Diversity, frequency and geographic distribution of genetic differences in 
potential vaccine antigens among malaria parasites,
Support for antigen diversity studies in vaccine development and predic‑
tion of vaccine efficacy
Distribution and quantitative level of parasite DNA in human populations Estimation of prevalence of submicroscopic infection
Determination of efficacy of diagnostic tools Surveillance for geospatial distribution of parasites carrying hrp2/3 deletion
Determination of RDT level of sensitivity
Detection of full range of parasite genotypes in a patient isolate Increased sensitivity to determine whether parasites recurring after drug 
treatment are new infections or recrudescence/relapse of initial infections
Detection of very low levels of parasite DNA in patient samples Improved detection of parasite prevalence even at low parasitaemia
Improved quantitation of delayed parasite clearance
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became quickly clear that logistical challenges are high 
on the list. For example, it is estimated that the estab-
lishment of an NGS facility costs USD 100,000–700,000 
for the sequencing instruments alone, depending on the 
actual platform to be established [9]. In SSA, this cost 
may increase, depending on how the equipment is pur-
chased. Equipment purchased through collaboration may 
come at reduced cost discounted through the collabora-
tor, but with loss of warranty and maintenance agree-
ments. On the other hand, those purchased through 
manufacturer’s sole agent in Africa are loaded with inter-
mediary costs and profits, expensive shipment and cus-
toms costs. Similarly, the cost and difficulty of obtaining 
required reagents is a major barrier; it was mentioned 
during the discussions by several delegates that when 
cost comparisons between SSA, with purchases being 
done through intermediate African or Middle Eastern 
vendors, and European/North American institutions, 
costs were threefold higher in most African sites. Fur-
thermore, often long clearance time at customs in SSA 
countries and as well, sudden changes of procedures at 
customs all add additional time and cost to the purchase. 
These costs barrier put together suggest that setting up a 
working sequencing platform is currently not affordable 
for most educational, research and clinical laboratories in 
developing countries.
To address some of the issues raised, the discussions 
centred on practical solutions. A first step might be the 
establishment of regional/sub-regional centres of excel-
lence with central NGS facilities that serve a network of 
institutions/sub-regions. Such centres should be main-
tained jointly, providing full access to the facilities and 
hands on training for researchers from joint institutions, 
enabling collective sample processing (also reducing 
costs) to address relevant research questions of public 
health interest (e.g. Table 1). These sub-regional facilities 
would be equipped with additional NGS platforms as the 
technology evolves.
Centres of excellence are already being established to 
provide high-quality sequencing services for several lab-
oratories and research groups. For example, the African 
Centre of Excellence for Genomics of Infectious Diseases 
(ACEGID) at Redeemer’s University (Nigeria) has been 
established with support from the World Bank and the 
US National Institute of Health (NIH) to serve several 
institutions in the surrounding region, including Senegal, 
Nigeria, and Sierra Leone [10]. The Africa Centre for Dis-
ease Control (CDC) is also engaging in the establishment 
of centres of excellence to track outbreaks and monitor 
re-emerging infectious diseases such as Lassa fever, and 
other viral haemorrhagic fevers, and Tuberculosis [11]. 
In West Africa, The Medical Research Council Unit The 
Gambia (MRCG-LSHTM) has purposed-built genomics 
and high-performance computing platforms accessible 
to West African networks, such as the PDNA. Creating 
NGS laboratory networks has several advantages; with 
higher projected use, they could negotiate with manu-
facturers, shippers and maintenance providers to ensure 
timely procurements and reduction of costs of reagents, 
and servicing of equipment. The network can have a 
single service contract for servicing of equipment and 
enabling visiting engineers service equipment from the 
whole sub-region in a single trip.
Data generation and handling
TNGS applications involve epidemiology and sequence 
data collection. In some cases, the data may carry meta-
data containing sensitive information such as personal 
data (name, gender, date of birth, race), medical history, 
and family history of diseases. Such information must be 
handled carefully with regulations to protect the privacy 
and maintain the anonymity of the source of the sample, 
within the standard guidelines for biomedical research 
ethics. These standards are set and well-regulated out-
side SSA. In SSA countries however, since TNGS is still 
rare, the regulatory frameworks that stipulate quality and 
proficiency standards, specimen shipment requirements, 
data protection, may not be available or not operational-
ized, if they do exist [12]. During deliberations, the need 
for harmonized SOPs and standardized forms/tools to be 
used across laboratories was highlighted. This includes 
strong data capture systems and well-trained staff, with 
clear guidelines for sample preparation prior to sequenc-
ing, quality management, data capture and data man-
agement. This needs to occur in the context of strong 
supervision by an experienced principle investigator and 
lab management team. Agreed minimum data formats, 
quality systems such as tables, pie-charts, and bar-charts 
will be standardized and adopted for both public health 
and research purposes. This standardized data quality 
systems is very important because, it will simplify data 
visualization and dissemination for both public health 
experts and research scientists. This will be supported by 
institutions, which will need the data.
It is clear there is a need for the establishment and 
implementation of the legal, ethical and regulatory 
framework to cover TNGS data collection, handling 
and sharing. For instance, after the initial data analysis 
and use (reports, publication, planning) by the research 
group, data should be deposited at centralized local and 
international repositories for access upon request and 
following set and agreed regulations between African 
partners. The data should be released as soon as it is 
made available and this decision on data release should 
be made by the data owners via data sharing agree-
ments. This could be guided by guidelines for the ethical 
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handling of samples for genomics studies, as stipulated 
by H3Africa [13].
Human resources (training) and infrastructural 
development for TNGS in Africa
Genomic data manipulation and analysis tools are essen-
tial for effective use of TNGS data. Genomics has become 
an interdisciplinary field that requires knowledge of biol-
ogy, chemistry, statistics, computer science and bioin-
formatics. Thus, institutions applying genomics research 
need personnel who are adequately trained to generate 
and explore data. This is most lacking in SSA countries. 
Several open source tools and codes are available for 
basic data analysis; however, these need advanced ana-
lytical skills to identify, customize and apply to questions 
and data different from what they were originally devel-
oped to do. In addition, many commercialized advanced 
tools are too expensive for institutions in the low-income 
countries or require complicated licensing procedures 
even for single users [14]. Thus the need for human 
resource development and building of the infrastructure 
for data analysis to ensure that the trained personnel 
will be ready to apply the acquired skills was discussed. 
The consensus was that, operationalizing TNGS in 
the African regional centres will require specific train-
ing in the following general approaches; introduction 
of basic principles in genomic technologies, laboratory 
methodologies and bioinformatics analysis of resulting 
data, establishing bioinformatics software capabilities, 
and exploring collaborative applications of the genomic 
capabilities in public health [14, 15]. It is important to 
note that once targeted sequencing is completed, a spe-
cific bioinformatics pipeline is required to properly turn 
the “raw sequencing reads” into actionable outputs as 
discussed in the bioinformatics tools in this series. Fur-
thermore, running and maintenance of bioinformatics 
pipelines need coding skills in multiple popular computer 
languages, e.g. R, Unix and python.
In addition, genomic data download and manipula-
tion require fast and stable Internet connections that are 
not always available in low income countries, especially 
in Africa [15, 16]. The group agreed that local control of 
data by those who plan and carry out the collection and 
appropriate preservation of samples is important. This 
can be efficiently accomplished if groups analyse their 
data locally, no matter where the sequences and initial 
bioinformatics pipelines were generated. This will require 
reliable high capacity Internet access: local hardware 
and human resources, for example, High Performance 
Computing (HPC) streams and human resources—
molecular biologists, computational biologists, and bioin-
formaticians. Currently, SSA has a few bioinformaticians 
and software users (biologists) capable of conducting this 
work. Initiatives like the H3AbioNet are building capacity 
for bioinformatics in Africa, but mainly in human genet-
ics. PDNA’s Wellcome Trust DELTAS grant, Developing 
Excellence in Genomics for Malaria Elimination (DEL-
GEME) on the other hand is training enthusiastic young 
Africans in bioinformatics, with emphasis on malaria 
(parasite, vector and vertebrate host). Partnerships with 
these initiatives and our collaborators for training and 
development of pipelines and tools for high quality data 
analysis by all was discussed. These technical supports 
could be both online and physical. Training programs 
in bioinformatics, including post-graduate diplomas, 
internships/short courses, post-doctoral fellowships and 
mentorship programmes with contributions from all 
stakeholders are all important.
The group also sees a future that utilizes innovative 
modern sequencing technologies with minimal infra-
structural requirements. Emerging genome sequenc-
ing technologies, such as MinION by Oxford Nanopore 
Technologies, which have minimized the requirements 
of adopting this NGS technology with affordable devices, 
preparation kits and standard computer or even portable 
devices (phone and tablets). Although the technology 
is still new and developing, it nonetheless represents a 
promising solution to a wide adoption of genomics across 
a range of genome sequencing applications [17].
Research funding
Lack of funding for biomedical research in Africa, has had 
an adverse consequence on the scientific development of 
the continent [15, 18–21]. Although the past decade has 
seen an increase in funding from research support ini-
tiatives like The Human Heredity and Health in Africa 
(H3Africa) initiative of the NIH and the Wellcome Trust 
[19], the DELTAS, FLAIR and APTI initiatives of the 
African Academy of Science, funding from Africa CDC, 
WAHO, ECOWAS, EAC and CEMAC, most African sci-
entist including those working on malaria remain largely 
underfunded. This is a major impediment to molecu-
lar research in general and malaria genomics. Current 
trends indicate successful grant funding mostly directed 
at networks or consortia rather than individual scientists. 
An example is the PDNA, which has been spearhead-
ing research and training to address malaria genomic 
diversity studies to support elimination. The workshop 
discussed the increase in governmental interest in some 
African countries and the need for more such support. 
A typical example can be found in South Africa where 
genomics research benefits from government-sponsored 
grants from the National Research Foundation and other 
agencies [22, 23]. Other African countries should emu-
late South Africa by allocating more public funds to sup-
port smaller TNGS studies in home countries.
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Strengthening of collaborations and publications
Genome science and technologies are transform-
ing life sciences globally in many ways and becoming a 
highly desirable area for international collaboration to 
strengthen global health. Collaboration between Afri-
can scientists and their northern partners in genomic 
research, such as TNGS for malaria research will 
undoubtedly result in a substantial increase in scientific 
capacity. Several initiatives have been set up to support 
such collaborations [24]. A recent example is the public 
health collaboration by The Genome Science Program 
at the LA National Laboratory, USA and research insti-
tutions in several developing countries including Jordan, 
Uganda, and Gabon [25]. PDNA and collaborators will 
provide support for establishing the centres of excellence 
through training. To ensure credit is given or assured for 
the many people who have contributed to the data gener-
ation and analysis pipeline: planning and execution of the 
original study, molecular analysis, bioinformatics to pro-
duce initial output, data management and analysis of the 
output in local context, data archive and use or reuse. All 
those who have worked on the project will be listed in any 
publications with their specific contribution. A Digital 
Object Identifier (DOI) will be assigned to each dataset 
and will be listed so that universities and research Insti-
tutions can recognize data generators when the DOI is 
quoted in a publication. Appropriate locations for perma-
nently archiving data are growing. For example, a Nature 
journal on archived data, facilitates uploading/archiving 
open source data and the accompanying metadata, and 
the group supported this approach to data reuse.
Summary and conclusions
The revolution in the sequencing world is opening new 
frontiers for biomedical research and Africa must ben-
efit from application of TNGS for malaria research. To 
achieve this, a number of challenges must be addressed. 
Firstly, there is the need for strategies to overcome finan-
cial and logistical challenges in establishing and main-
taining infrastructure. This includes long-term support 
for scientist and infrastructure (stable environmental 
temperature, stable electrical power supply, reliable and 
efficient Internet access). Stable power and internet are 
becoming more accessible across Africa, but heavily 
biased toward urban agglomerates away from the centres 
of malaria transmission. Secondly, most African malaria 
research scientists and technicians are experienced biolo-
gists, but lack bioinformatics and quantitative/numeric 
expertise. Training a biologist in the techniques of 
genome science and data generation is relatively straight-
forward, but achieving informatics proficiency is a major 
hurdle, given very basic computational knowledge. 
Thirdly, funding remains a major challenge to research 
and training to boost NGS adoption and translation 
across most biomedical research themes in Africa. Devel-
opment of regional or sub-regional centres of excellence 
will allow for reduced financial burden on scientists and 
facilitate collaboration. Centres will be collaborative hubs 
that will support molecular surveillance with high tem-
poral, geographic, and information resolution to support 
local public health authorities in identifying and moni-
toring important phenotypes such as drug resistance. A 
network of African TNGS centres that can rapidly pro-
vide high-resolution genomic data that will help improve 
the speed and accuracy of detection and monitoring, and 
reduce the global threat from malaria drug resistance is 
urgently required.
Successful scientific partnerships and sustainable techni-
cal capacity are essential for establishing TNGS for malaria 
research in Africa. More local governmental support and 
funding for malaria TNGS research will be required. Sci-
entists must engage the policy makers more effectively in 
research activities. This will require a carefully crafted reg-
ulatory framework for community engagement in genom-
ics, data collection and storage, and regionally coordinated 
TNGS wet laboratory procedures, data ownership, man-
agement and analysis. Sustainability of the TNGS science 
capabilities with partners is a key concern.
There is the need for a continued improvement of 
local expertise through training. Sustainable use of the 
established TNGS technologies will be strengthened 
by performing regular research projects. Over time, 
this approach will enable African scientists to gain the 
expertise to develop genomic capabilities and continue 
on a path to sustainability. The question, however, is 
who should be directing these decisions and how? Since 
PDNA is leading in these discussions, the network will 
continue to drive the questions to be addressed with the 
TNGS platform and support the training of African sci-
entist in bioinformatics.
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